End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 CNY | +1.03% | +5.21% | +3.62% |
Apr. 29 | Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Sales 2022 | 5.15B 713M | Sales 2023 | 5.03B 696M | Capitalization | 9.28B 1.28B |
---|---|---|---|---|---|
Net income 2022 | 574M 79.44M | Net income 2023 | 567M 78.47M | EV / Sales 2022 | 1 x |
Net cash position 2022 | 3.52B 487M | Net cash position 2023 | 3.37B 467M | EV / Sales 2023 | 1.17 x |
P/E ratio 2022 |
15.1
x | P/E ratio 2023 |
16.2
x | Employees | 6,062 |
Yield 2022 |
3.23% | Yield 2023 |
-
| Free-Float | 68.41% |
1 day | +1.03% | ||
1 week | +5.21% | ||
Current month | +5.21% | ||
1 month | +7.68% | ||
3 months | +13.37% | ||
6 months | -3.92% | ||
Current year | +3.62% |
Managers | Title | Age | Since |
---|---|---|---|
Wu Jun Huang
CEO | Chief Executive Officer | 56 | 15-12-10 |
Qiu Lin Peng
DFI | Director of Finance/CFO | 58 | 09-07-30 |
Zi Qiang Zhang
BRD | Director/Board Member | 53 | 12-12-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shu Tian Tu
BRD | Director/Board Member | 62 | - |
Zheng Lian Xiao
BRD | Director/Board Member | 56 | 06-12-24 |
Qiu Lin Peng
DFI | Director of Finance/CFO | 58 | 09-07-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 4 M€ | -2.96% | ||
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 6.87 | +1.03% | 52,496,370 |
24-05-07 | 6.8 | +0.29% | 24,853,730 |
24-05-06 | 6.78 | +3.83% | 39,493,840 |
24-04-30 | 6.53 | +0.15% | 46,035,360 |
End-of-day quote Shenzhen S.E., May 07, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+3.62% | 1.32B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.87% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- 000650 Stock